Antiseptic

 

(57) Abstract:

Field of application: agriculture, veterinary medicine. Essence: to improve antimicrobial and preventive activities antiseptic agent, comprising the active ingredient is a Quaternary ammonium salt, a mineral or organic acid and solvent, as Quaternary ammonium salts contains cetyltrimethylammonium bromide or cetyltrimethylammonium chloride, or N-alkyl-N-alkoxycarbonylmethyl-hexahydroazepin chloride or pyridinium bromide or pyridinium chloride, or 1,2-ethylene-bis- (N-dimethylcarbamate)-ammonium dichloride, or dialkyldimethyl ammonium chloride, or alkyldimethylbenzylammonium chloride at a certain ratio of components. 3 C.p. f-crystals.

The present invention relates to the field of agriculture, mainly veterinary medicine, and can be used for treatment of healthy and damaged epithelial tissues of animals for the prevention of infectious diseases and purulent complications.

Known antiseptic agent, comprising the active ingredient is a Quaternary ammonium salt, a mineral or organic acid and solvent.with. USSR N 1459005, MKI A 61 L Pecci and other representatives of the gram-negative microflora - permanent and transitory contaminants various objects of the external environment, including epithelial tissue of animals.

The aim of the invention is to increase and prophylactic antimicrobial activity funds while reducing the irritating properties with respect to epithelial tissues, as well as increase keratoplasticheskie steps.

This objective is achieved in that the antiseptic agent, comprising the active ingredient is a Quaternary ammonium salt, a mineral or organic acid and solvent, as Quaternary ammonium salts contains cetyltrimethylammonium chloride or cetyltrimethylammonium bromide, or N-alkyl-N-alkoxycarbonylmethyl-hexahydroazepin chloride or pyridinium bromide or pyridinium chloride, or 1,2-ethylene-bis- (N-dimethylcarbamate)-ammonium dichloride, or dialkyldimethylammonium chloride, or alkyldimethylbenzylammonium chloride in the following ratio, wt. %:

the pyridinium chloride or pyridinium bromide, or cetyltrimethylammonium chloride, or cetyltrimethylammonium bromide, or N-alkyl-N-alkoxycarbonylmethyl chloride, or 1,2 - ethylene-bis-(N-dimethylchrolotetracycline or organic acid 0,05 - 1,0; solvent - rest.

This goal is achieved by the fact that as a mineral or organic acid is used boric or glycolic acid, or acetic acid, or sulfamic, or lactic or propionic acid.

This goal is achieved by the fact that as the solvent medium contains water or 1 to 15% solution of glycol in water, or in 1 - 10% aqueous solution of ethyl alcohol or isopropyl, 0,5 - 5,0% solution of ammonium chloride in 1 - 10% aqueous solution of ethyl alcohol or isopropyl.

This goal is achieved by the fact that as glycol use propylene glycol (PG), polyethylene glycol-200 (PEG-200, peg-300 (PEG-300), polyethylene glycol-400 (PEG-400), polypropylenglycol (BCP), triethylene glycol (TEG).

Quaternary (bischetvertichnoe) ammonium germicidal compounds and other cationic surfactants are used as antiseptics for hand surgeons, operating margins, bladder (Century. And. the Vashkov. Means and methods of sterilisation used in medicine. M, "Medicine", 1973, S. 216 - 220), as well as for the prevention and treatment of chronic carriage by long SiS surgery. L. , "Medicine", 1987, S. 75 - 90 and others; T. Franklin, J. Snow. Biochemistry of antimicrobial action. M., Mir, 1984, S. 72).

Most low molecular weight glycols characterized by the absence of toxicity (with the exception of ethylene glycol), which find varied applications in pharmaceutical and perfume industry, as well as sources of carbohydrate food and antimicrobial agents for parenteral administration (C. P. of vitolina, M. J. Girgensons and Some other side of the metabolism of 1,2-propane diol and 1,3-butanediol when administered parenterally in combination with glucose and sorbitol. The nutrition. 1973, 2, 10 -18; L. I. Yudin, G. A. Markman and other Glycols and their use in biology and medicine. IMEI, 1984, S. 17-23).

Lactic, propionic, acetic, glycolic, like many other organic acids, being non-toxic metabolites of biological processes, most of them are used as food additives and preservatives. Boric acid as a mild, well-tolerated integumentary tissue antiseptic used for the renovation of the mucous membranes. Sulfamic acid as a low toxic substance widely used to remove mineral deposits and maul acipan in everyday life and as a preservative of food.

In the scientific and patent literature is not well-known technical solutions similar to the claimed, i.e., the proposal meets the criterion of "novelty."

We first established that the use of only the above-mentioned components in the stated amounts to produce a new effect - increasing bactericides, keratoplasticheskie steps, i.e., the proposal meets the criterion of "inventive step".

All materials used in the claimed technical solution components are manufactured by the domestic industry, i.e., the proposal meets the criterion of "industrial applicability".

The invention is illustrated in the following examples.

Example 1. Antiseptic agent 1 is prepared by mixing 0.05 g of sulfamic acid with 50 g of the solvent - water and add 0.01 g of Quaternary ammonium compounds (QAC) - cetyltrimethylammonium chloride (CTAG), stirring until dissolved, then the solvent bring the mixture to 100 g, thus obtaining the structure 1 in the following ratio, wt.%:

HOUR (CTAH) - 0,01

The sulfamic acid is 0.05

The solvent (water) - Rest

Example 2. Antiseptic sreeramula until dissolved. Then the solvent bring the mixture to 100 g, while receiving part 2 in the following ratio, wt.%:

HOUR (CTAH) - 2,5

The sulfamic acid - 0,5

The solvent (water) - Rest

Example 3. Antiseptic 3 is prepared by mixing 1.0 g of sulfamic acid, 50 g of the solvent - water, stirring to dissolve with 5.0 g HOUR (CTAG). Then the solvent bring the mixture to 100 g, while receiving part 3 in the following ratio, wt. %:

HOUR (CATCH) - 5,0

The sulfamic acid - 1,0

The solvent (water) - Rest

Example 4. Antiseptic 4 is prepared by mixing 0.05 g of glycolic acid with 50 g of the solvent is 1% aqueous solution of GHGs and add 0.01 g HOUR - cetyltrimethylammonium bromide (CTAB), stirring until dissolved, then the solvent bring the mixture to 100 g, while receiving structure 4 in the following ratio, wt.%

HOUR (CTAB) - 0,01

The glycolic acid is 0.05

The solvent (1% aqueous solution GHG) - Rest

Example 5. Antiseptic 5 is prepared by mixing 0.5 g of glycolic acid, 50 g of the solvent is 1% aqueous solution of GHGs and gaballa the composition 5 in the following ratio of components, wt.%:

HOUR (CTAB) - 2,5

The glycolic acid - 0,5

The solvent (1% water

the solution GHG) - Rest

Example 6. Antiseptic 6 is prepared by mixing 1.0 g of glycolic acid, 50 g of solvent of 1% aqueous solution of GHG add 5.0 g HOUR (CTAB), stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving structure 6 in the following ratio, wt.%:

HOUR (CTAB) - 5,0

The glycolic acid is 0.05

The solvent (1% aqueous solution GHG) - Rest

Example 7. Antiseptic agent 7 is prepared by mixing 0.05 g of acetic acid with 50 g of the solvent - 7,5%-aqueous solution of GHGs and add 0.01 g H - N-alkyl-N-alkoxycarbonylmethyl - hexahydroazepin chloride (AGW were determined), stirring until dissolved, then the solvent bring the mixture to 100 g, while receiving part 7 at the following ratio, wt.%:

HOUR (AGW WERE DETERMINED) - 0,01

Acetic acid - 0,05

The solvent (a 7.5% aqueous solution GHG) - Rest

Example 8. Antiseptic 8 is prepared by mixing 0.5 g of acetic acid, 2.5 g HOUR (AGW were determined with 50 g of the solvent - 7,5%-aqueous solution of PG, stirring until complete solution components wt.%:

HOUR (AGW WERE DETERMINED) - 2,5

Acetic acid and 0.5

The solvent (a 7.5% aqueous solution GHG) - Rest

Example 9. Antiseptic 9 prepared by mixing 1.0 g of acetic acid, 50 g of the solvent - 7,5%-aqueous solution of PG, stirring to dissolve with 5.0 g HOUR (AGW were determined). Then the solvent bring the mixture to 100 g, while receiving part 9 in the following ratio, wt.%:

HOUR (AGW WERE DETERMINED) - 5,0

Acetic acid - 1,0

The solvent (a 7.5% aqueous solution GHG) - Rest

Example 10. Antiseptic 10 prepared by mixing 0.05 g of lactic acid and 50 g of the solvent - 15%-aqueous solution of PG and add 0.01 g HOUR - cetylpyridinium chloride (CPH), stirring until dissolved, then the solvent bring the mixture to 100 g, thus obtaining the structure 10 in the following ratio, wt.%:

HOUR (CPH) - 0,01

The lactic acid - 0,05

The solvent (15% aqueous solution GHG) - Rest

Example 11. Antiseptic 11 is prepared by mixing 0.5 g of lactic acid, 50 g of the solvent - 15%-aqueous solution of PG and add 2.5 g HOUR (CPH), stirring until dissolved. Then the mixture dissolve the

The lactic acid - 0,5

The solvent (15% aqueous solution GHG) - Rest

Example 12. Antiseptic agent 12 is prepared by mixing 1.0 g of lactic acid, 50 g of the solvent - 15%-aqueous solution of PG, stirring to dissolve with 5.0 g HOUR (CPH). Then the solvent bring the mixture to 100 g, while receiving part 12 in the following ratio, wt.%:

HOUR (CPH) - 5,0

The lactic acid - 1,0

The solvent (15% aqueous solution GHG) - Rest

Example 13. Antiseptic 13 is prepared by mixing 0.05 g of boric acid with 50 g of the solvent is 10% PG solution in 1% ethyl alcohol and add 0.01 g of H - pyridinium bromide (CDC), stirring until dissolved. Next, the solvent bring the mixture to 100 g, while receiving structure 13 in the following ratio, wt.%:

HOUR (CDC) - 0,01

Boric acid is 0.05

The solvent (10% aqueous solution of GHGs in 1% ethyl alcohol) - Rest

Example 14. Antiseptic 14 is prepared by mixing 0.5 g of boric acid, 50 g of the solvent - 7,5%-aqueous solution of GHG 3.5% ethyl alcohol and add 2.5 g HOUR (CDC), stirring until dissolved. Then RAS wt.%:

HOUR (CDC) - 2,5

Boric acid and 0.5

The solvent (a 7.5% aqueous solution of GHG 3.5% ethyl alcohol) - Rest

Example 15. Antiseptic agent 15 is prepared by mixing 1.0 g of boric acid, 50 g of the solvent - 15%-aqueous solution PG 7% ethyl alcohol, stirring to dissolve with 5.0 g HOUR (CDC). Then the solvent bring the mixture to 100 g, thus obtaining the composition in the following ratio, wt.%:

HOUR (CDC) - 5,0

Boric acid - 1,0

The solvent (15% aqueous solution PG 7% ethyl alcohol) - Rest

Example 16. Antiseptic 16 is prepared by mixing 0.05 g of sulfamic acid with 50 g of the solvent is 0.5% aqueous solution of ammonium chloride and add 0.01 g HOUR - 1,2-ethylene-bis-(N-dimethylcarbamate)-ammonium dichloride (atony), stirring until dissolved, then the solvent bring the mixture to 100 g, while receiving part 16 in the following ratio, wt.%:

HOUR (atoni) - 0,01

The sulfamic acid is 0.05

The solvent (0.5% aqueous solution of ammonium chloride) - Rest

Example 17. Antiseptic 17 prepared by mixing 0.5 g of sulfamic sour is dissolved. Then the solvent bring the mixture to 100 g, while receiving part 17 in the following ratio, wt.%:

HOUR (atoni) - 2,5

The sulfamic acid - 0,5

The solvent (a 2.5% aqueous solution of ammonium chloride) - Rest

Example 18. Antiseptic 18 is prepared by mixing 1.0 g of sulfamic acid, 50 g of solvent of 5.0% aqueous solution of ammonium chloride, stirring to dissolve with 5.0 g of H - etoniya. Then the solvent bring the mixture to 100 g, the receiving part 18 in the following ratio, wt.%:

HOUR (atoni) - 5,0

The sulfamic acid - 1,0

The solvent (5,0% aqueous solution of ammonium chloride) - Rest

Example 19. Antiseptic 19 prepared by mixing 0.05 g of lactic acid and 50 g of the solvent is 1% aqueous solution of polyethylene glycol-200 (PEG-200) and add 0.01 g HOUR (atony), stirring until dissolved, then the solvent bring the mixture to 100 g, while receiving part 19 in the following ratio, wt.%:

HOUR (atoni) - 0,01

The lactic acid - 0,05

The solvent (1,0% aqueous solution of PEG-200) - Rest

Example 20. Antiseptic add 2.5 g HOUR (atony), stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving structure 20 in the following ratio, wt.%:

HOUR (atoni) - 2,5

The lactic acid - 0,5

The solvent (a 7.5% aqueous solution of PEG-300) - Rest

Example 21. Antiseptic 21 is prepared by mixing 1.0 g of lactic acid, 50 g of the solvent - 15%-aqueous solution of PEG-400, stirring to dissolve with 5.0 g HOUR (atony). Then the solvent bring the mixture to 100 g, while receiving part 21 in the following ratio, wt.%:

HOUR (atoni) - 5,0

The lactic acid - 1,0

The solvent (15% aqueous solution of PEG-400) - Rest

Example 22. Antiseptic 22 is prepared by mixing 0.05 g of acetic acid with 50 g of the solvent is 1% aqueous solution of polypropylenglycol (BCP) and add 0.01 g HOUR (atony), stirring until dissolved, then the solvent bring the mixture to 100 g, while receiving part 22 in the following ratio, wt.%:

HOUR (atoni) - 0,01

Acetic acid - 0,05

The solvent (1% aqueous solution BCP) - Rest

Example 23. Antiseptic 23 are billaut 2.5 g HOUR (atony), stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving part 23 in the following ratio, wt.%:

HOUR (atoni) - 2,5

Acetic acid and 0.5

The solvent (a 7.5% aqueous solution TEG) - Rest

Example 24. Antiseptic 24 is prepared by mixing 1.0 g of acetic acid, 50 g of the solvent is 1% aqueous solution of TEG in 1% ethyl alcohol, stirring to dissolve with 5.0 g HOUR (atony). Then the solvent bring the mixture to 100 g, while receiving structure 24 in the following ratio, wt.%:

HOUR (atoni) - 5,0

Acetic acid - 1,0

The solvent (1% TAG in 1% aqueous solution of ethyl alcohol) - Rest

Example 25. Antiseptic 25 prepared by mixing 0.05 g of glycolic acid with 50 g of the solvent - 7,5%-aqueous solution of PEG-300 3.5% ethyl alcohol and add 0.01 g HOUR (atony), stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving part 25 in the following ratio, wt.%:

HOUR (atoni) - 0,01

The glycolic acid is 0.05

The solvent (a 7.5% solution of PEG-300 3.5% aqueous solution with the acid, 50 g of the solvent - 15%-aqueous solution of PEG-300 in 7% aqueous solution of ethyl alcohol and add 2.5 g HOUR (atony), stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving part 26 in the following ratio, wt.%:

HOUR (atoni) - 2,5

Acetic acid and 0.5

The solvent (15% solution of PEG-300 in 7% aqueous solution of ethyl alcohol) - Rest

Example 27. Antiseptic 27 prepared by mixing 1.0 g of boric acid, 50 g of the solvent - 15%-aqueous solution of PEG-400 in 7% aqueous solution of ethyl alcohol, stirring to dissolve 0.5 g HOUR (atony). Then the solvent bring the mixture to 100 g, while receiving part 27 in the following ratio, wt.%:

HOUR (atoni) - 0,5

Boric acid - 1,0

The solvent (15% solution of PEG-400 in 7% aqueous solution of ethyl alcohol) - Rest

Example 28. Antiseptic 28 prepared by mixing 0.05 g of boric acid with 50 g of the solvent - 15%-aqueous solution of BCP in 7% aqueous solution of ethyl alcohol and add 0.01 g HOUR (atony), stirring until dissolved. Then the solvent bring the mixture to 100 g, while the R> The solvent (15% solution of BCP in 7% aqueous solution of ethyl alcohol) - Rest

Example 29. Antiseptic 29 prepared by mixing 0.5 g of boric acid, 50 g of the solvent is 1%-aqueous solution of TEG in 1% solution of ethyl alcohol and add 2.5 g HOUR (atony), stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving part 29 in the following ratio, wt.%

HOUR (atoni) - 2,5

Boric acid and 0.5

The solvent (1% solution TAG in 1% aqueous solution of ethyl alcohol) - Rest

Example 30. Antiseptic 30 is prepared by mixing 1.0 g of boric acid, 50 g of the solvent - 15%-aqueous solution of TEG in 7% aqueous solution of ethanol, stirring to dissolve with 5.0 g HOUR (atony). Then the solvent bring the mixture to 100 g, while receiving structure 30 in the following ratio, wt.%:

HOUR (atoni) - 5,0

Boric acid - 1,0

The solvent (15% solution of TEG in 7% aqueous solution of ethyl alcohol) - Rest

Example 31. Antiseptic 31 is prepared by mixing 0.05 g of propionic acid, 50 g of the solvent - 70% aqueous solution of isopropyi. Then the solvent bring the mixture to 100 g, while receiving part 31 in the following ratio, wt.%:

HOUR (DADMAC) - 0,01

The propionic acid - 0,05

The solvent (70% aqueous solution of isopropyl alcohol) - Rest

Example 32. Antiseptic 32 is prepared by mixing 0.5 g of propionic acid, 50 g of the solvent - 70% aqueous solution of ethyl alcohol and add 2.5 g of H - DADMAC, stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving structure 32 in the following ratio, wt.%:

HOUR (DADMAC) - 2,5

The propionic acid and 0.5

The solvent (70% aqueous solution of ethyl alcohol) - Rest

Example 33. Antiseptic 33 is prepared by mixing 1.0 g of propionic acid, 50 g of the solvent - water, stirring to dissolve with 5.0 g of H - alkyldimethylbenzylammonium chloride (ketamin). Then the solvent bring the mixture to 100 g, while receiving part 33 in the following ratio, wt.%:

HOUR (ketamin) - 5,0

The propionic acid - 1,0

The solvent (water) - Rest

Example 34. Antiseptic 34 prepared by the ora of ethyl alcohol and add 0.01 g HOUR (ketamin), stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving structure 34 in the following ratio, wt.%:

HOUR (ketamin) - 0,01

The lactic acid - 0,05

The solvent (0.5% solution of ammonium chloride in 10% alcohol ethyl) - Rest

Example 35. Antiseptic 35 is prepared by mixing 0.2 g of lactic acid and 50 g of the solvent is 1%-aqueous solution of ammonium chloride in 10% aqueous solution of isopropyl alcohol and add 2.0 g HOUR (ketamin), stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving structure 35 in the following ratio, wt.%:

HOUR (ketamin) - 2,0

The lactic acid - 0,2

The solvent (1% solution of ammonium chloride in 10% isopropyl alcohol) - Rest

Example 36. Antiseptic 36 is prepared by mixing 0.6 g of lactic acid and 50 g of solvent a 5% aqueous solution of ammonium chloride in 10% aqueous solution of isopropyl alcohol and add 1.0 g HOUR ketamine, stirring until dissolved. Then the solvent bring the mixture to 100 g, while receiving part 36 in the following ratio of the components is of a 10% alcohol isopropyl) - Else

Example 37. Experimental studies of the bactericidal properties of the proposed antiseptics were carried out by standard methods. As the test microbes used reference crop (reference strains) Staph. aurens, PCs 209-P (representative gram-positive microflora) and E. coli pieces 1257 (representative of gram-negative microflora). Bactericidal concentration was determined by standard suspension method; for all variants of the preparation prepared according to the invention (ex. 1 - 36), with 10 min exposure in relation to both cultures (Staph. aurens and E. coli), it is 0.5%. Under these conditions, the drug asaur prepared according to known recipe, with respect to E. coli provided a bactericidal effect at 1% concentration. In experiments with short-term exposures were also obtained better results: drugs 1 - 36 undiluted and at a dilution of 1:1, i.e. 50% concentration on the drug when exposed to microbial suspension for 12 - 15 caused the death of 97% to 100% of the microorganisms of both species, whereas known asaur showed bactericidal to E. coli only 94 - 96%, thus yielding significantly for all variants of the proposed tools. Anti-Christ.>/P>Biological effects of drugs on top of the tissue studied by systematically drawing on areas nepilirovanny skin (34 cm) rabbits for 30 days, with subsequent review of allergenic action. During the entire observation period, no signs of irritation, inflammation and sensitization was not observed. In control animals, the skin of which was treated in a similar way control abepura, noted a transient hyperemia and melkopuzyrchatuyu the desquamation of the superficial layer of the epithelium.

Thus, the claimed drug is superior to known means asaur on bactericidal activity against gram-negative bacteria, however, better tolerated integumentary tissues of warm-blooded animals.

1 1. Antiseptic agent, comprising the active ingredient is a Quaternary ammonium salt, a mineral or organic acid and a solvent, characterized in that the Quaternary ammonium salt contains cetyltrimethylammonium bromide or cetyltrimethylammonium chloride, or N-alkyl-N-alkoxycarbonylmethyl-hexahydroazepin chloride or pyridinium bromide or pyridinium chloride, or 1,2-ethylene-bis-(N-dimethyl-carrierunlock the ratio of components wt.%: 3 Cetyltrimethylammonium bromide, or cetyltrimethylammonium chloride or N-alkyl-N-alkoxycarbonylmethyl-hexahydroazepin chloride or pyridinium bromide or pyridinium chloride, or 1,2-ethylene-bis-(N-dimethyl-cardellicchio)-ammonium dichloride, or dialkyldimethylammonium chloride, or alkyldimethylbenzylammonium chloride7 0,01 - 5,0 3 Mineral or organic acid 7 0,05 - 1,0 3 the Solvent 7 Else 2 2. Means under item 1, characterized in that as a mineral or organic contains boric acid or glycolic acid, or acetic acid, or sulfamic, or lactic or propionic acid. 2 3. Tool for PP.1 and 2, characterized in that the solvent contains water or 1 to 15% solution of glycol in water or in 1 - 10% aqueous solution of ethyl alcohol or isopropyl, or 0.5 - 5% solution of ammonium chloride in 1 - 10% aqueous solution of ethyl alcohol or isopropyl. 2 4. Tool for PP.1 to 3, characterized in that as the glycol contains propylene glycol, peg-200, peg-300, peg-400, polypropylenglycol, triethylene glycol.

 

Same patents:
The invention relates to the cleaning and sterilizing medical instrument, in particular endoscopes, and can be used in medical institutions using endoscopes to diagnose and/or treat

The invention relates to compositions and method to quickly and efficiently determine whether it's been functional component, such as catalase, transparent solution, such as hydrogen peroxide solution, by mixing with the specified functional component of an effective amount of vitamin B-12 so that when adding the mixture into a clear solution, this solution took the pink color

The invention relates to medicine and can be used in clinical medicine as antimicrobial, disinfectant and sterilizing agent, used as a skin antiseptic for treatment of surgical and injectable fields elbow bends donors

The invention relates to medical engineering, in particular to a device for cleaning and sterilization of endoscopes, and can be used in medical institutions using endoscopes to diagnose and/or treat

The invention relates to medical engineering, in particular to a device for cleaning and sterilization of endoscopes, and can be used in medical institutions using endoscopes to diagnose and/or treat
The invention relates to the field of medical technology
The invention relates to medical equipment
The invention relates to medicine, namely to surgery, and can be used for sanitation of the abdominal cavity in the peritonitis

Disinfectant for // 2117491
The invention relates to chloractive drugs used for disinfection
The way the animals // 2115434

The invention relates to the development of methods of disposal of sewage in which the neutralized effluent can be used in agriculture, in the production of organo-mineral fertilizers, etc
The invention relates to medicine, namely dezinficiruy-detergents intended for disinfection of surfaces in premises, sanitary-technical equipment, linens, Housewares, medical devices, and for sterilization of medical products
Biocidal tool // 2108809
The invention relates to agriculture, in particular animal, and can be used during the disinfection of veterinary stations

The invention relates to the field of biotechnology, and in particular to substances used to combat bacterial contamination, and can be used in applied biotechnology, medicine, veterinary

The invention relates to agriculture

Antimicrobial agent // 2098135
The invention relates to medicine and relates to antimicrobial drugs to combat diseases caused by pathogenic microorganisms

Disinfectant // 2083228
The invention relates to chemical means of combating microorganisms

The invention relates to medicine, namely to the means for sterilizing and washing from biological fluids and can be used for processing instruments, apparatus, and fixtures reuse

The invention relates to medicine, in particular to pulmonology, and for the treatment of acute pneumonia
Up!